Photo taken from Erika Hamilton/X
Jun 24, 2024, 13:33
Erika Hamilton’s insights into the future of ADCs in oncology – Sarah Cannon Research Institute
Sarah Cannon Research Institute shared the following post on LinkedIn:
“We are thrilled to share the latest advancements in cancer research from our experts at Sarah Cannon Research Institute, presented at the 2024 Annual ASCO Meeting. Erika Hamilton, MD’s insights into the future of antibody-drug conjugates (ADCs) highlight exciting new possibilities in oncology. Discover more about these therapies here.”